[Bleomycin, vinca alkaloid and cis-diamminedichloroplatinum combination chemotherapy for advanced testicular tumors]. 1984

I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada

Thirteen patients with advanced testicular tumors (seminoma 2, non-seminoma 11) were treated with combination chemotherapy involving BLM, vinca alkaloid and CDDP (BVP) as induction therapy and followed with CPM, VCR and CDDP as maintenance therapy. BVP and COP administration was repeated every 3 and 4 to 8 weeks for 1 year, if there were no serious side effects. The overall response rate (CR + PR) was 92% with a 69% CR rate. At a mean follow-up of 30 months (7-52 month range), 54% of the patients were alive with no evidence of disease. Bulky metastases, failure to respond to prior chemotherapy and teratomatous metastases were considered to be poor prognostic factors. The toxicity of BVP was similar to that reported for CDDP, except that allergic reaction occurred in 3 patients after several courses of treatment. Two of the 3 went into anaphylactic shock.

UI MeSH Term Description Entries
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004407 Dysgerminoma A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1646) Disgerminoma,Disgerminomas,Dysgerminomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
September 1977, Annals of internal medicine,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
February 2002, The Journal of urology,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
January 1980, Cancer,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
May 1979, Lancet (London, England),
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
April 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
January 1980, Cancer treatment reports,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
January 1984, Medical and pediatric oncology,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
August 1984, Hinyokika kiyo. Acta urologica Japonica,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
October 1978, Cancer,
I Fukui, and M Yokokawa, and K Takagi, and M Katoh, and Y Higashi, and S Gotoh, and H Sekine, and Y Tachibana, and N Kobayashi, and T Yamada
January 1975, Oncology,
Copied contents to your clipboard!